Skip to main content
Equibles

ESSEX INVESTMENT MANAGEMENT CO LLC

Position in CSBR — Champions Oncology, Inc.

CIK 201772 BOSTON, MA
Back to CSBR Full portfolio

Position in CSBR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$112,241
+$7,310 QoQ
Shares Held
18,221
-0.2% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 28 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSBR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names. CSBR ranks #13 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 43,567 $13,771,093
2 MIRM
Mirum Pharmaceuticals, Inc.
 105,669 $12,370,669
3 TVTX
Travere Therapeutics, Inc.
 133,866 $7,604,927
4 JAZZ
Jazz Pharmaceuticals plc
 21,665 $5,220,615
5 OCUL
Ocular Therapeutix, Inc
 482,154 $4,734,752
6 INSM
INSMED Inc
 42,991 $4,583,700
7 PGEN
Precigen, Inc.
 706,294 $4,025,875
8 AXSM
Axsome Therapeutics, Inc.
 16,244 $3,976,043

All Filings in CSBR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,241 18,221
2026-03-31 $104,931 18,249
2025-12-31 $126,100 18,249
2024-03-31 $378,280 77,200
2023-12-31 $433,864 77,200
2023-09-30 $654,130 105,335
2023-06-30 $710,349 111,340
2023-03-31 $432,773 107,655
2022-12-31 $485,524 107,655
2022-09-30 $807,832 107,711
2022-06-30 $920,600 115,075
2022-03-31 $935,559 115,075
2021-12-31 $889,696 106,423
2021-09-30 $913,866 89,507
2021-06-30 $936,754 91,124
2021-03-31 $1,019,621 90,232
2020-12-31 $973,603 90,232
2020-09-30 $1,333,739 144,188
2020-06-30 $1,625,802 170,063
2020-03-31 $1,258,466 170,063